PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA
- PMID: 1796399
PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA
Abstract
The antigen levels of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) were assayed in the plasma and in the euglobulin fraction, and their contributions to the euglobulin clot lysis time (ECLT) and t-PA activity were analyzed. Total and free PAI-1 levels in both fractions showed significant positive correlation with ECLT (p less than 0.001), whereas t-PA antigen level did not have a high correlation coefficient with ECLT. t-PA activity showed significant negative correlation with ECLT (p less than 0.001) and positive correlation with free t-PA level (p less than 0.001), which was calculated by the ratio of the concentrations of t-PA-PAI-1 complex and the free PAI-1. Thus free t-PA seems to dissolve the euglobulin clot and its concentration seems to be controlled by the concentration of free PAI-1. These findings were confirmed by the analyses of the effects of C1-inactivator and antibody against t-PA to regular ECLT and kaolin activated ECLT, the latter of which was only inhibited by the addition of C1-inactivator whereas the former was inhibited by anti-t-PA antibody.
Similar articles
-
Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.Life Sci. 2009 Jul 31;85(5-6):220-5. doi: 10.1016/j.lfs.2009.05.014. Epub 2009 Jun 3. Life Sci. 2009. PMID: 19500599
-
Diurnal variation of the fibrinolytic system.Thromb Haemost. 1988 Jun 16;59(3):495-9. Thromb Haemost. 1988. PMID: 3142085
-
Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.Thromb Haemost. 1990 Feb 19;63(1):82-6. Thromb Haemost. 1990. PMID: 2111051
-
New aspects in thrombotic research: complement induced switch in mast cells from a profibrinolytic to a prothrombotic phenotype.Pathophysiol Haemost Thromb. 2003 Sep-2004 Dec;33(5-6):438-41. doi: 10.1159/000083842. Pathophysiol Haemost Thromb. 2003. PMID: 15692257 Review.
-
[Euglobulin lysis time].Nihon Rinsho. 1999 Sep;57 Suppl:546-7. Nihon Rinsho. 1999. PMID: 10543173 Review. Japanese. No abstract available.
Cited by
-
Accelerated fibrinolysis and its propagation on vascular endothelial cells by secreted and retained tPA.J Biomed Biotechnol. 2012;2012:208108. doi: 10.1155/2012/208108. Epub 2012 Oct 14. J Biomed Biotechnol. 2012. PMID: 23118500 Free PMC article.
-
Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis.Curr Drug Targets. 2019;20(16):1695-1701. doi: 10.2174/1389450120666190715102510. Curr Drug Targets. 2019. PMID: 31309890 Free PMC article. Review.
-
Plasma fibrinogen, tissue plasminogen activator, plasminogen activator inhibitor 1, and their related factors in three Japanese population samples.Environ Health Prev Med. 1998 Oct;3(3):158-63. doi: 10.1007/BF02931707. Environ Health Prev Med. 1998. PMID: 21432496 Free PMC article.
-
High PAI activity with correlation to triglyceride and HDL cholesterol values in patients with coronary artery disease with no difference in survivors of myocardial infarction.Ann Hematol. 1993 Nov;67(5):237-44. doi: 10.1007/BF01715054. Ann Hematol. 1993. PMID: 8241347
-
Evaluation of thrombomodulin/thrombin activatable fibrinolysis inhibitor function in plasma using tissue-type plasminogen activator-induced plasma clot lysis time.Res Pract Thromb Haemost. 2024 May 28;8(4):102463. doi: 10.1016/j.rpth.2024.102463. eCollection 2024 May. Res Pract Thromb Haemost. 2024. PMID: 39026660 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous